Relationship Between Circulating Cytokines And Crohn‘S Disease Development In Patients From Baghdad City
Keywords:
N\AAbstract
This study was conducted in Baghdad city to evaluate the relationship between the circulatory cytokines association with crohn‘s disease. The cytokines levels and activity were studied on five cytokines; lL-23, IL-12, IL-6 and INF-γ, TNF-α. Circulating cytokines values were compared according to the disease activity in active and queisnt phases.
Results showed that IL-23 significantly the higher level as compared to other cytokines in CD patients, followed by INF-γ. The lower value was found in IL-2 as compared to others. In the other hand, cytok9nes activity in active and queicent phases in the CD patients IL23 showed the high value, where as, TMF-α was recorded the moderate value, and the lower value was recorded to IL-12 as compared to the active and quiescent phases. The differences were not statistically significant.
The study showed the association of some circulating cytokines and Crohn’s disease in patients, further studies are needed to determine the effects of the cytokine IL-23 and INF- γ in management of CD and IBD diseases.
Downloads
Metrics
References
Kotaro, Ogawa et al. (2012). Profiles of circulating cytokines in patients with Cronh’s disease under maintenance therapy with infliximab. Journal of Corhn’s and Colitis, Vol. 6. Pp 529-535.
Petagna L., Antonili, A., Ganimi, C. et al. (Pathophysiology of Crohn’s disease inflammation and recurrence. Biol. Direct. MC1D.
Kashan, S. Hamasur (2020). Prevalence of oral manifestations of inflammatory bowel disease in patients admitted to Sulaymaniyah teaching hospital – Iraq. Al-Kindy College medical journal, Vol. 16. No 1.
Fuss, I. Becker; Yang, Z. Groden; Hornung, R.L. Heller (2006). Both IL-12 and IL-23 are synthesized durind active croyn’s disease and are down regulated by treatment with anti IL-12 monoclonal antibody . Inflamm Bowel Dis,12. Pp9-15.
Liu, Z. Yadav; Su ,J. Chen; Tang, M. (2011). The increased expression of Il-23 in inflammatory Bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory response and cytotoxicity. J Leukoc Biol., 89. 597-606.
Bin, L, YU, Q,Yanan, L, X., Langting, S. Ying Ying, M. and Xiahui, S. (2023). Circulating levels of cytokines Caruso. C. (2019). MIG in Crohns disease. Cli. Ter. 170(3):pp206-210
Lucaciu, LA.; Llies, M.; Vesa, SC.; Seicean, R.; Din, S. and luga, CA. ETAL,,(2021). Serum interleukin IL-23 and IL-17 profile in inflammatory bowel disease (IBD) patients could differentiate between severe and non-severe disease. J. Per. Med. 11(11):1131
Geoergakis, MK.; Gill, D.; Rannikmae, K.; Traylor, M.; Anderson, CD. AND Lee, JM., ETAL,,(2019).Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 139(2); pp,256-268.
Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al.. Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 52(1):65–70. doi: [11]- Tessarollo L. Pleiotropic functions of neurotrophins in development. Cytokine al..
Best, W. ; Becktel, J.; Singlton, J. W. and Kern, F. Development of Crohns disease activity index. Natural cooperative Crohns disease study. Gastroenterology 70 1976 pp; 439-444.
Brennan, F. M.; Chantry, D.; Jackson, A.; Miani, R. and Feldmann, M. lnhibitory effect of TNF- α
Gust, T.; Lemmers, A.; Louis, E; Nicaise, C.; Qertinmont, E. and Belaiche, J.et al..(2005). Profiles of soluble cytokines reseptors in Crohns disease. Gut. 54; pp. 65-70
Schmidt, C.; Giese, T.; Ludwig, B,; Mueller-Molaian, l.; Marth, T. AND Zeumem,
S. et al..(2005). Expression of interleukin-12-related cytokine transcripts in inflammatory succeptiblity to Corhns disease with not in ulcerative colitis .Inflamm. bowel, Dis.11; 1623.
Schmechel, S. ; Konrad, A.; Diegelmann, J.; Glas, J.; Wetzke, M. and Paschos, E. et al..(2008). Linking genetic susceptibility to Crohns disease with Th17 cell function. IL22 serum levels are increased in Crohns disease and correlate with disease activity and IL-23 R genotype status. Inflamm. Bowel. Dis. 14; 204-212.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
